about
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell modelsExpression and function of NKRP1A molecule on human monocytes and dendritic cellsImatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemiaDefective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survivalHuman gammadelta T cells: a nonredundant system in the immune-surveillance against cancer.Selective role of mevalonate pathway in regulating perforin but not FasL and TNFalpha release in human Natural Killer cellsPECAM-1, apoptosis and CD34+ precursors.Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment.Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-I or by target cells.Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to autoreactivity: evidence for the involvement of natural cytotoxicity receptors (NCR) and NKG2DMechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases.Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.NK cell autoreactivity and autoimmune diseases.Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation.Stress immunity in lymphomas: mesenchymal cells as a target of therapy.Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy.Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vδ 2 T lymphocytes in non-Hodgkin lymphomas.Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing.Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.Functional association of platelet endothelial cell adhesion molecule-1 and phosphoinositide 3-kinase in human neutrophils.NKRP1A molecule is involved in transendothelial migration of CD4+ human T lymphocytes.Expression of N-CAM by human renal cell carcinomas correlates with growth rate and adhesive properties.LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.How to exploit stress-related immunity against Hodgkin's lymphoma: Targeting ERp5 and ADAM sheddases.CD31-triggered rearrangement of the actin cytoskeleton in human natural killer cells.CD31/PECAM-1-driven chemokine-independent transmigration of human T lymphocytes.CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D.Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation.Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells.IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules.The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells.Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans.Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-β(1), soluble Fas ligand, and soluble Class I human leukocyte antigen.
P50
Q27704009-D00591D5-473C-4F9B-AD25-EF91B076D787Q28256187-093C80D2-F357-4796-B6B4-CDA0FB726441Q28477798-577FD8BB-EDE4-4EE6-ADEE-6EED9DC2C2CFQ34166502-13FE3D69-5259-4D75-B989-2D69D8E3AC76Q34451498-E6BAF348-E6F8-4200-BE1C-D464E8F6879AQ34500914-F827D7A8-939E-4F31-9CBF-8CB41BF4A416Q34717893-C1D3D8C5-C1A0-4032-9235-78B4A7D92B01Q35932028-367113A0-6A50-4C6B-A131-012BCD8433AAQ36038492-3A005EA9-04EA-4AD8-97C6-FDB963E3A160Q36281238-5309D495-678C-43B8-A560-0786DC956E0AQ36502302-DB897DC3-9189-4536-B369-C7881C5A837DQ36619346-EC2ADE3F-D586-45B2-882B-343C086D479CQ37066094-EAA778F5-EBF2-4870-A655-442C3C8408E2Q37279445-ED20AB7A-AD7E-42C5-9445-EF42ECA3BC1AQ37552129-D906AD64-1D8F-4818-AC8F-9C7C9C20B94CQ37630626-914CBCA3-0884-4ED9-801E-B3E9D90BF26EQ38175723-6508011F-B207-421A-A180-33B818BB4527Q38198424-B02C73C2-F431-4990-A01E-B72F60C8DC8CQ38271585-8A3DF074-E61C-4FD7-A26C-55FD18B20487Q39158802-C91E83EE-BA4D-4286-88E0-28C0159247F2Q40252845-FD7AF61A-0F8B-46C7-A1FD-918DB2095C22Q40315561-878FA2F1-7204-4FDC-B281-592E226BBD23Q40382706-101D05AA-CD53-4F88-9721-3334DDA85010Q40479856-9E30A5C3-A6D4-4BA6-9991-81590173AEB7Q40596798-A31513F1-F568-4F85-8B4A-E345760AB500Q40748772-123FB5C5-143E-45F7-B067-2BB6113F4633Q41002627-AAEE61E4-670A-4E51-B796-1D96E34FBE97Q41106417-548C88E6-183A-4FCE-88F1-1901AF8391EDQ41441028-7BA4A9E2-AF70-421C-8940-36FD302C7126Q42383966-8B44A0E3-9D5D-45EE-AC3C-73BCAD44BC54Q42740131-9A625CA3-34C6-42FB-9223-A4AF2A3295FAQ42814825-22EBC40F-08EC-4D5F-AF47-FF5F9CB3FE04Q42814837-7D99EACC-5130-45C3-84BF-AD339363BDE4Q43745317-84A4FE16-08AA-49B8-909C-A099D619958AQ44189856-19A86B20-C8F3-4793-A2AC-0CF329EC3FD1Q44385638-02170C2A-26B6-4B11-BDD6-55D3B7C76B7AQ44632544-76E7A65E-1569-44EF-B67B-D21EACB99420Q45157658-671F71CB-7E38-4992-9D7B-2E63E1561916Q46036025-E7BBD9B7-876D-4012-B325-BD4424196851Q50549305-E71595A8-6B49-4B64-A90F-CDBD69237A64
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria R Zocchi
@es
Maria R Zocchi
@nl
Maria R Zocchi
@sl
Maria R. Zocchi
@en
type
label
Maria R Zocchi
@es
Maria R Zocchi
@nl
Maria R Zocchi
@sl
Maria R. Zocchi
@en
prefLabel
Maria R Zocchi
@es
Maria R Zocchi
@nl
Maria R Zocchi
@sl
Maria R. Zocchi
@en
P106
P1153
7006408475
P21
P31
P496
0000-0002-0022-8385